GlassScriptPhysician profile
Carli B Thomas
NPI 1205287000
$2,022.29
in general payments reported to CMS, 2019-2025
15 companies · $358 in 2025
The $358 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50.13 · 2021: $375 · 2022: $287 · 2023: $303 · 2024: $649 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $764.43 | 2021-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $440.63 | 2021-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $193.53 | 2020-2025 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $181.27 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $129.07 | 2022-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $111.65 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $33.22 | 2024 | Flumist Quadrivalent |
| Neos Therapeutics, LP | $31.66 | 2021 | |
| Sobi, INC | $27.41 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $26.66 | 2021 | |
| Glaxosmithkline, LLC. | $23.43 | 2020 | |
| Sanofi Pasteur INC. | $18.66 | 2021 | |
| Vertical Pharmaceuticals, LLC | $14.71 | 2024 | Relexxii |
| Teva Pharmaceuticals USA, INC. | $13.58 | 2021 | |
| Adlon Therapeutics L.P. | $12.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carli Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.